WGSWW | GeneDx Holdings Corp. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.0947 - 0.1736
52 Week Range	0.0947 - 0.1736
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	85,209
Average Volume	N/A
Shares Outstanding	12,086,022,396
Market Cap	2,146,606,131
Sector	Healthcare
Industry	Medical - Healthcare Information Services
IPO Date	N/A

Valuation
Profitability
Growth
Health
P/E Ratio	N/A
Forward P/E Ratio	N/A
EPS	N/A
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	1,000
Country	USA
Website	WGSWW

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.

WGSWW's peers: WGS, ICUCW, HUMAW, SHCRW, SLGCW

*Chart delayed

Analyzing fundamentals for WGSWW we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is very bad and Health is very weak. For more detailed analysis please see WGSWW Fundamentals page.

Watching at WGSWW technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, but short-term trend is bearish. More technicals details can be found on WGSWW Technicals page.